Extended lamivudine treatment in patients with HBeAg negative HBVDNA positive chronic hepatitis B (CHB)

被引：0
|
作者：
Tassopoulos, NC
Anagnostopoulos, GD
Delladetsima, JK
Barbati, C
Angelopoulou, P
Sipsa, V
Hatzakis, A
机构：
[1] Western Attica Gen Hosp, Athens, Greece
[2] Laikon Gen Hosp, Athens, Greece
[3] Red Cross Gen Hosp, Athens, Greece
[4] Univ Athens, Sch Med, GR-11527 Athens, Greece
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1187
引用
收藏
页码：456A / 456A
页数：1
相关论文
共 50 条
  • [1] Natural history of extended lamivudine (LAM) treatment in patients with HBeAg negative chronic hepatitis B (CHB).
    Tassopoulos, NC
    Delladetsima, JK
    Anagnostopoulos, GD
    HEPATOLOGY, 2001, 34 (04) : 633A - 633A
  • [2] Natural history of extended lamivudine (LAM) treatment in patients with HBeAg negative chronic hepatitis B (CHB)
    Tassopoulos, N
    Anagnostopoulos, G
    Sypsa, V
    Delladetsima, J
    Hantzakis, A
    JOURNAL OF HEPATOLOGY, 2002, 36 : 248 - 248
  • [3] Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B
    Rizzetto, M
    Tassopoulos, NC
    Goldin, RD
    Esteban, R
    Santantonio, T
    Heathcote, EJ
    Lagget, M
    Taak, NK
    Woessner, MA
    Gardner, SD
    JOURNAL OF HEPATOLOGY, 2005, 42 (02) : 173 - 179
  • [4] Response to extended lamivudine treatment of HBeAg negative chronic hepatitis B.
    Andreone, P
    Hussain, MT
    Lok, AS
    Gramenzi, A
    Cursaro, C
    Lorenzini, S
    Porzio, F
    Margotti, M
    HEPATOLOGY, 2001, 34 (04) : 321A - 321A
  • [5] Entecavir versus lamivudine for HBeAg positive and negative chronic hepatitis B
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2006, 45 (03) : 457 - 460
  • [6] Lamivudine therapy in HBeAg negative chronic hepatitis B patients
    Guclu, E.
    Batirel, A.
    Ince, N. Koc
    Ogutlu, A.
    Durmaz, Y.
    Ozdemir, D.
    Geyik, M. F.
    Karabay, O.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 444 - 444
  • [7] Clinical & histological outcome of extended lamivudine in patients with HBeAg negative chronic hepatitis B.
    Esteban, R
    Goldin, RD
    Tassopoulos, NC
    Rizzetto, M
    Santantonio, T
    Heathcote, J
    Woessner, M
    Taak, NK
    HEPATOLOGY, 2001, 34 (04) : 446A - 446A
  • [8] Biochemical response to lamivudine treatment in HBeAg negative chronic hepatitis B patients in Iran
    Amir Houshang Mohammad Alizadeh
    Mitra Ranjbar
    Babak Karimi
    Saeed Hatami
    World Journal of Gastroenterology, 2006, (26) : 4203 - 4205
  • [9] Biochemical response to lamivudine treatment in HBeAg negative chronic hepatitis B patients in Iran
    Alizadeh, Amir Houshang Mohammad
    Ranjbar, Mitra
    Karimi, Babak
    Hatami, Saeed
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (26) : 4203 - 4205
  • [10] The impact of HBeAg positive/negative and HBVDNA loads on the prediction of chronic severe hepatitis B
    Sun, Qingfeng
    Xu, Daozhen
    Lv, Yong
    Wu, Jinguo
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A120 - A121
12345